Iran’s domestically produced COVID-19 vaccine receives approval
Iran's Health Minister, Saeed Namaki, announced on Monday that the COVIRAN/ Barekat Coronavirus vaccine, had received approval for public inoculations.
“A legal Commission gave approval to the backup vaccine for emergency use. The Barekat complex can now distribute the vaccines it produced, God willing, the vaccine will be added to the national vaccination programme as of next week,“ Namaki said in a statement.
He said that Iran had gone through nearly a year of intensive work to join the Club of countries with the capacity to scale up production for Coronavirus vaccines.
COVIRAN/Barekat was unveiled on 29 December 2020 with mass production beginning on March 29th.
It has been developed by Shifa Pharmed, a subsidiary of the Iranian economic and industrial conglomerate, Setad.
Production capacity is slated to reach 12 to 15 million doses per month by the end of the summer.
Iran has been battling one of the largest outbreaks of coronavirus in the Middle East. It is among the first countries which started developing a vaccine against the coronavirus and now four companies are endeavoring to release their products by September, and inoculate the general population.
Iran hopes that domestic initiatives could significantly boost vaccine supplies for the nationwide inoculation program which started last year.
Iran takes delivery of 1 million doses of coronavirus vaccines
The Iranian Red Crescent Society (RCS) has taken delivery of one million doses of coronavirus vaccines amid a reported shortage in supplies that has caused delays to giving second shots to the elderly.
A spokesman of the Food and Drug Administration of Iran said on Thursday that the new consignment of vaccines had arrived in Tehran’s Imam Khomeini airport early in the morning.
Kianoush Jahanpour corrected a earlier statement by the RCS suggesting that the new batch of coronavirus vaccines had contained two million doses, saying the supply delivered to the health ministry had contained one million doses.
Earlier RCS statements suggest the international organization will import up to 7.5 million doses of coronavirus vaccines in the calendar month to June 21.
Authorities said earlier this month that most of the vaccines planned to be imported by the RCS will be the Chinese-made Sinopharm jabs and will be supplied by the Chinese Red Cross authority.